Jantovia-Mxr 100/1000mg Tablet

Jantovia-Mxr 100/1000mg Tablet is a combination medication containing two active ingredients: sitagliptin & metformin. Sitagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, while metformin is a biguanide antidiabetic agent. This tablet is formulated to provide effective management of type 2 diabetes mellitus by addressing different aspects of glucose regulation.

Uses:

Jantovia-Mxr 100/1000mg Tablet is prescribed for the following purposes:

1. Control of blood sugar levels in individuals with type 2 diabetes mellitus.
2. Improvement of glycemic control in conjunction with diet and exercise.
3. Reduction of hemoglobin A1c (HbA1c) levels, indicating long-term glucose control.
4. Prevention of complications associated with uncontrolled diabetes, such as cardiovascular disease and neuropathy.

Side Effects:

Although Jantovia-Mxr 100/1000mg Tablet  is generally well-tolerated, some individuals may experience the following side effects:

1. Nausea and vomiting
2. Diarrhea
3. Abdominal discomfort or pain
4. Headache
5. Hypoglycemia (low blood sugar) when used with other antidiabetic medications
6. Upper respiratory tract infections

It is important to consult a healthcare professional if any adverse reactions occur.

Precautions:

Before using Jantovia-Mxr 100/1000mg Tablet, it is important to consider the following precautions:

1. Inform your doctor about any pre-existing medical conditions, especially kidney or liver problems.
2. Use with caution in elderly patients as they may be more susceptible to lactic acidosis, a rare but serious side effect associated with metformin.
3. Regular monitoring of kidney function and blood glucose levels is recommended during treatment.
4. Avoid excessive alcohol consumption while taking this medication as it may increase the risk of lactic acidosis.
5. Inform your healthcare provider about all other medications, including over-the-counter drugs and supplements, to avoid potential drug interactions.

When Not to Use:

Jantovia-Mxr 100/1000mg Tablet  should not be used in the following circumstances:

1. Known hypersensitivity or allergy to sitagliptin, metformin, or any of the ingredients in the formulation.
2. Severe kidney impairment (creatinine clearance <30 mL/min) or end-stage renal disease.
3. Acute or chronic metabolic acidosis, including diabetic ketoacidosis.
4. History of lactic acidosis or predisposing factors such as heart failure or respiratory insufficiency.
5. Pregnancy or breastfeeding, unless the potential benefits outweigh the risks and under medical supervision.

In summary, Jantovia-Mxr 100/1000mg Tablet is a combination medication used for the management of type 2 diabetes mellitus. It effectively controls blood sugar levels and reduces the risk of complications associated with diabetes when used as directed under medical supervision.